J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 72 (1991), 299-305; DOI 10.1099/0022-1317-72-2-299
© 1991 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, J.
Right arrow Articles by McGregor, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, J.
Right arrow Articles by McGregor, W. G.
Agricola
Right arrow Articles by Roberts, J.
Right arrow Articles by McGregor, W. G.

Inhibition of mouse retroviral disease by bioactive glutaminase-asparaginase

Joseph Roberts and W. Glenn McGregor{dagger}

Department of Basic Pharmaceutical Sciences, College of Pharmacy, The University of South Carolina, Columbia, South Carolina 29208, U.S.A.

Glutamine depletion strongly inhibits the replication of Rauscher murine leukaemia retrovirus (RLV) in vitro. Pseudomonas 7A glutaminase-asparaginase (PGA), capable of depleting glutamine and asparagine for prolonged periods, was used to determine the therapeutic effectiveness of glutamine depletion in mice infected with RLV or Friend virus. During PGA treatment of viraemic animals, serum reverse transcriptase activity fell to control levels and infected animals did not develop splenomegaly. The therapeutic results obtained with PGA compared favourably with those of azidothymidine given intraperitoneally at 30 mg/kg/day. Western blots performed on splenic tissue from control and treated animals indicated that glutamine depletion prevented readthrough of an amber codon at the gag-pol junction, stopping translation of viral mRNA at that point. Treatment of RLV-infected animals with PGA resulted in nearly a 200% increase in mean survival time even when therapy was initiated late in the course of the disease. To our knowledge, this is the first demonstration that a nutrient required for viral replication can be enzymically depleted in vivo to inhibit viral replication.

{dagger} Present address: Carcinogenesis Laboratory, Department of Microbiology and Department of Biochemistry Michigan State University, East Lansing, Michigan 48824, U.S.A.

Received 18 July 1990; accepted 18 October 1990.


This article has been cited by other articles:


Home page
J. Nutr.Home page
A. Spittler, R. Oehler, P. Goetzinger, S. Holzer, C. M. Reissner, F. Leutmezer, V. Rath, F. Wrba, R. Fuegger, G. Boltz-Nitulescu, et al.
Low Glutamine Concentrations Induce Phenotypical and Functional Differentiation of U937 Myelomonocytic Cells
J. Nutr., November 1, 1997; 127(11): 2151 - 2157.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1991 by the Society for General Microbiology.